# TuHURA Biosciences, Inc./NV (HURA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from TuHURA Biosciences, Inc./NV's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/HURA/mda/fy2025/): filed 2026-03-31; accession 0001193125-26-134950 (https://www.sec.gov/Archives/edgar/data/1498382/000119312526134950/hura-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/HURA/mda/fy2024/): filed 2025-03-31; accession 0000950170-25-047921 (https://www.sec.gov/Archives/edgar/data/1498382/000095017025047921/hura-20241231.htm)
- [FY 2024 MD&A](/company/HURA/mda/a-0000950170-24-113321/): filed 2024-10-07; accession 0000950170-24-113321 (https://www.sec.gov/Archives/edgar/data/1498382/000095017024113321/ktra-20240630.htm)
- [FY 2023 MD&A](/company/HURA/mda/fy2023/): filed 2023-09-18; accession 0000950170-23-048588 (https://www.sec.gov/Archives/edgar/data/1498382/000095017023048588/ktra-20230630.htm)
- [FY 2022 MD&A](/company/HURA/mda/fy2022/): filed 2022-09-27; accession 0000950170-22-018865 (https://www.sec.gov/Archives/edgar/data/1498382/000095017022018865/ktra-20220630.htm)

Back to /company/HURA/